Incepta Pharmaceuticals
Incepta Pharmaceuticals is a Bangladesh-based pharmaceutical manufacturer founded in 1999, producing tablets, capsules, oral liquids, and other dosage forms. The privately held company employs 5,001–10,000 people and operates from Dhaka.
- Company typePrivate
- Founded1999
- HeadquartersDhaka, Bangladesh
- Headcount5,001–10,000
- GTM typeB2B
- OfferingHardware or Manufacturing
What Incepta Pharmaceuticals does
Incepta Pharmaceuticals is a privately held pharmaceutical manufacturer headquartered in Dhaka, Bangladesh, founded in 1999. The company produces tablets, capsules, oral liquids, and other dosage forms, operating as a for-profit generic pharmaceutical company. With a workforce of 5,001 to 10,000 employees, Incepta operates at significant scale relative to the Bangladesh pharmaceutical market, positioning it among the larger domestic manufacturers in the country.
The company's core business is the formulation and manufacturing of finished pharmaceutical products across multiple delivery formats. Its product portfolio spans oral solids (tablets and capsules), liquid orals, and other dosage forms. Incepta's private ownership and absence of public listing information suggest a closely-held operating structure with no disclosed investor base, parent company, or subsidiaries in the source material.
Business model details, including pricing, distribution channels, customer segmentation, and revenue mechanics, were not disclosed in the available data. The company's website (inceptapharma.com) was not accessible for direct extraction at the time of analysis, limiting granular detail on its product catalog, manufacturing footprint, export activity, and commercial operations. As a result, third-party verification of revenue, market share, and growth metrics was not possible from the source material provided.
Incepta Pharmaceuticals firmographics
Firmographics- Name
- Incepta Pharmaceuticals
- Website
- https://inceptapharma.com
- Company type
- Private
- Founded year
- 1999
- Headcount range
- 5,001–10,000 employees
- Short description
- Incepta Pharmaceuticals is a Bangladesh-based pharmaceutical manufacturer founded in 1999, producing tablets, capsules, oral liquids, and other dosage forms. The privately held company employs 5,001–10,000 people and operates from Dhaka.
- Ownership category
- akta.pro rank
Incepta Pharmaceuticals industry classification
Industry- Product category
- Generic Pharmaceuticals
- NAICS
- Pharmaceutical Preparation Manufacturing (325412), Pharmaceutical and Medicine Manufacturing (32541), Pharmaceutical and Medicine Manufacturing (3254), Medicinal and Botanical Manufacturing (325411)
- SIC
- Pharmaceutical Preparations (2834), Medicinal Chemicals & Botanical Products (2833)
- akta.pro primary industry
- Generic APIs & Intermediates (Active Ingredients) (HLAIABAG)
- akta.pro secondary industry
- Primary Care & General Medicine Pharmaceuticals (HLAIAAAA)
Keywords
Where Incepta Pharmaceuticals is headquartered
LocationHeadquarters
- HQ city
- Dhaka
- HQ country
- Bangladesh
- HQ region
- Asia
Markets served
Incepta Pharmaceuticals business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Supply Chain, Operations, Personnel, Technology or R&D, Infrastructure, Marketing or Sales
Incepta Pharmaceuticals product offering
Product offeringCore offering
Incepta Pharmaceuticals manufactures and sells finished pharmaceutical dosage forms, including tablets, capsules, oral liquids, and other dosage formats. The company operates as a domestic Bangladesh-based pharmaceutical producer founded in 1999.
Differentiator
Problem solved
Functional benefit
Products and services
- Pharmaceutical tablets
Companies that use Incepta Pharmaceuticals
Customer profileIdeal customer profiles1 record
Incepta Pharmaceuticals technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Incepta Pharmaceuticals competitors and assessment
Company assessmentDirect peers
- Renata Limited: Bangladesh-based pharmaceutical manufacturer with finished dosage forms and animal health — competes in the same domestic market and in export channels as Incepta.
- Beximco Pharmaceuticals: Bangladeshi pharmaceutical manufacturer producing finished dosage forms (tablets, capsules, injectables) for domestic and export markets — directly comparable in geography, product mix, and business model.
- Square Pharmaceuticals: Largest Bangladeshi pharma company producing a broad range of generic finished dosage forms, with significant export presence — most direct domestic peer to Incepta in scale and product portfolio.
Regional players
- ACME Laboratories: Bangladesh pharmaceutical manufacturer producing generic finished dosage forms — same geography, same product categories, overlapping customers.
- Healthcare Pharmaceuticals: Bangladesh-based generic pharma manufacturer with dosage form production comparable to Incepta, focused on domestic and regional export markets.
Broad incumbents
- Cipla: India-based global generic pharmaceutical major producing a broad portfolio of finished dosage forms — competes with Incepta in Africa, Asia, and other emerging markets with deeper regulatory approvals.
- Sun Pharmaceutical Industries: India-headquartered global generic and specialty pharma manufacturer with extensive finished dosage form portfolio — comparable business model at much larger scale.
- Dr. Reddy's Laboratories: Indian integrated pharmaceutical company with strong generics, API, and biosimilars businesses — comparable business model with deeper regulated-market presence.
- Aurobindo Pharma: Large Indian generic manufacturer with vertically integrated API and finished dosage form operations — directly comparable in scale and product mix from a cost-arbitrage geography.
- Lupin Limited: India-based global generic pharmaceutical company with broad finished dosage form portfolio and significant emerging-market footprint — comparable generic-pharma business model.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat3 records
Key risks4 records
Key highlights5 records
Customer concentration
Incepta Pharmaceuticals social profiles
Digital presenceIncepta Pharmaceuticals financial estimates
Financial estimateRevenue estimate
Valuation estimate
Incepta Pharmaceuticals leadership team
Management profileNumber of profiles
Incepta Pharmaceuticals funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Incepta Pharmaceuticals M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Incepta Pharmaceuticals
What does Incepta Pharmaceuticals do?
Incepta Pharmaceuticals manufactures and sells finished pharmaceutical dosage forms, including tablets, capsules, oral liquids, and other dosage formats. The company operates as a domestic Bangladesh-based pharmaceutical producer founded in 1999.
When was Incepta Pharmaceuticals founded?
Incepta Pharmaceuticals was founded in 1999. It employs 5,001 to 10,000 people.
Where is Incepta Pharmaceuticals based?
Incepta Pharmaceuticals is headquartered in Dhaka, Bangladesh, in the Asia region.
Who are Incepta Pharmaceuticals's main competitors?
Direct peers on record are Renata Limited, Beximco Pharmaceuticals and Square Pharmaceuticals. Regional players are ACME Laboratories and Healthcare Pharmaceuticals. Broad incumbents are Cipla, Sun Pharmaceutical Industries, Dr. Reddy's Laboratories, Aurobindo Pharma and Lupin Limited.
Does Incepta Pharmaceuticals have an API?
No public API is recorded for Incepta Pharmaceuticals.
What industry is Incepta Pharmaceuticals in?
Incepta Pharmaceuticals's product category is Generic Pharmaceuticals. Its primary akta.pro industry code is HLAIABAG, Generic APIs & Intermediates (Active Ingredients), with a secondary code of HLAIAAAA, Primary Care & General Medicine Pharmaceuticals. Its NAICS code is 325412 and its SIC code is 2834.